List of largest biotechnology and pharmaceutical companies
The following is a list of the independent biotechnology companies listed on a stock exchange (as indicated) with current market capitalization of at least USD 10 billion, in decreasing order.
The list does not include biotechnology companies that are currently owned by, or a part of, larger pharmaceutical groups.
Rankings
| Rank[N 1] | Company | Largest Market Cap (USD billions) | Market Cap in 2020 (USD billions)[1] | Market Cap in 2019 (USD billions) | Market Cap in 2018 (USD billions) | Market Cap in 2017 (USD billions) | Market Cap in 2016 (USD billions)[2][3] | Market Cap in 2015 (USD billions)[4] | Market Cap in 2014 (USD billions)[5] | Market Cap in 2013 (USD billions) |
|---|---|---|---|---|---|---|---|---|---|---|
1  |  Johnson & Johnson[P]NYSE: JNJ |
399.9 (Dec 2020) | 399.99 | 385.0 | 346.1 | 375.4 | 314.1 | 284.2 | 277.8 | 258.3 |
2  1 |  Roche[P]SIX: ROG |
291.1 (Dec 2020) | 291.12 | 281.1 | 209.3 | 216.7 | 192.1 | 234.7 | 258.5 | 240.3 |
| 3 2 | Pfizer[P] NYSE: PFE |
310.5 (Jul 2000) | 208.11 | 216.7 | 259.7 | 215.9 | 196.3 | 199.3 | 205.4 | 196.0 |
4  1 | Novartis[P] NYSE: NVS |
275.2 (Jul 2015) | 202.09 | 240.0 | 200.0 | 196.7 | 170.5 | 206.1 | 229.8 | 195.0 |
| 5 1 | Merck & Co.[P] NYSE: MRK |
232.9 (Dec 2019) | 201.80 | 232.9 | 205.8 | 153.3 | 164.3 | 147.6 | 166.9 | 146.5 |
| 6 | Abbott Laboratories[P] NYSE: ABT |
190.4 (Dec 2020) | 190.44 | 153.5 | 126.8 | 99.3 | 56.4 | 67.0 | 67.9 | 59.3 |
| 7 2 | AbbVie[B] NYSE: ABBV |
196.2 (Jan 2018) | 182.27 | 130.9 | 146.3 | 154.4 | 100.2 | 96.8 | 104.1 | 83.8 |
| 8 |  Novo Nordisk[P]NYSE: NVO |
161.9 (Dec 2020) | 161.99 | 137.1 | 111.9 | 131.2 | 92.6 | 153.9 | 125.4 | - |
| 9 2 | Eli Lilly & Co[P] NYSE: LLY |
158.3 (Dec 2020) | 158.30 | 126.9 | 125.6 | 93.0 | 80.9 | 93.4 | 76.6 | 57.0 |
| 10 3 | Bristol-Myers Squibb[P] NASDAQ: BMY |
137.8 (Dec 2020) | 137.85 | 105.0 | 85.0 | 100.3 | 98.2 | 114.8 | 97.6 | 87.2 |
| 11 4 | Amgen[B] NASDAQ: AMGN |
145.8 (Dec 2019) | 129.79 | 144.6 | 128.8 | 126.2 | 108.9 | 122.5 | 93.1 | 78.7 |
| 12 2 |   AstraZeneca[P]LSE: AZN |
130.8 (Dec 2019) | 129.44 | 130.8 | 96.2 | 87.9 | 68.8 | 85.8 | 88.9 | 74.6 |
| 13 4 |  Sanofi[P]NYSE: SNY |
151.3 (Sep 2014) | 120.66 | 63.5 | 108.4 | 108.2 | 101.8 | 111.8 | 138.1 | 142.0 |
| 14 2 | /
|
174.9 (May 2006) | 90.15 | 117.2 | 94.8 | 87.9 | 93.3 | 97.6 | 128.9 | 129.6 |
| 15 1 | Stryker Corporation[P] NYSE: SYK |
88.8 (Dec 2020) | 88.81 | 78.5 | 58.6 | 58.0 | 45.1 | 34.7 | 35.7 | 28.4 |
| 16 2 | Zoetis[P] NASDAQ: ZTS |
76.6 (Aug 2020) | 75.97 | 63.2 | 41.4 | 35.1 | 26.4 | 23.8 | 21.6 | 16.3 |
| 17 3 | Gilead Sciences[B] NASDAQ: GILD |
179.6 (Jun 2013) | 71.93 | 82.3 | 81.6 | 93.6 | 96.6 | 145.8 | 109.0 | 78.4 |
| 18 6 |  Daiichi Sankyo[P]NASDAQ: DSNKY |
45.3 (Dec 2019) | 63.92 | 45.3 | 22.7 | 27.5 | 35.3 | 38.8 | 33.2 | 28.7 |
| 19 1 | Vertex Pharmaceuticals[B] NASDAQ: VRTX |
78.9 (Jul 2020) | 61.33 | 56.3 | 42.2 | 37.9 | 18.3 | 31.0 | 28.7 | 17.4 |
| 20 4 |  Bayer[P]FWB: BAYN |
129.0 (Mar 2015) | 58.12 | 80.1 | 63.1 | 101.9 | 85.3 | 103.2 | 113.2 | 117.4 |
| 21 2 | Takeda Pharmaceutical[P] NASDAQ: TAK |
61.5 (Dec 2019) | 56.78 | 61.5 | 52.9 | 40.2 | 45.6 | 47.8 | 37.5 | 34.3 |
| 22 1 | Illumina[B] NASDAQ: ILMN |
56.0 (Jul 2019) | 53.51 | 48.2 | 44.1 | 40.2 | 39.4 | 35.4 | 28.6 | 25.7 |
| 23 2 | Regeneron Pharmaceuticals[B] NASDAQ: REGN |
61.4 (Aug 2015) | 52.52 | 41.2 | 40.3 | 40.4 | 39.3 | 56.5 | 42.0 | 27.4 |
| 24 3 | Biogen[B] NASDAQ: BIIB |
111.7 (Mar 2015) | 38.66 | 54.7 | 63.5 | 67.4 | 61.6 | 68.3 | 79.7 | 66.1 |
| 25 2 | Alexion Pharmaceuticals[P] NASDAQ: ALXN |
47.0 (Jul 2015) | 33.52 | 24.3 | 21.7 | 26.7 | 27.4 | 43.1 | 36.7 | 26.0 |
| 26 3 | Seagen[B] NASDAQ: SGEN |
38.2 (Oct 2020) | 34.44 | 19.5 | 13.8 | |||||
| 27 1 | Astellas[P] TYO: 4503 |
40.6 (Dec 2015) | 27.52 | 32.7 | 23.8 | 29.3 | 25.7 | 40.6 | 35.8 | 27.6 |
| 28 4 | Genmab[B] NASDAQ: GMAB |
25.9 (Nov 2020) | 25.53 | 14.5 | 10.6 | 10.8 | 10.8 | 8.8 | 3.8 | 2.6 |
| 29 1 | Eisai Pharmaceutical[P] TYO: 4523 |
37.3 (Dec 2016) | 19.93 | 21.5 | 23.0 | 24.5 | 37.3 | 28.8 | 30.2 | 28.7 |
| 30 | Incyte[P] NASDAQ: INCY |
31.2 (Mar 2017) | 19.25 | 18.8 | 13.5 | 18.3 | 15.4 | 10.6 | 7.3 | 4.6 |
| 31 | BioMarin[P] NASDAQ: BMRN |
24.0 (Jul 2015) | 16.03 | 15.2 | 15.1 | 18.3 | 20.4 | 13.8 | 12.9 | 10.8 |
| 32 10 |  / Teva Pharmaceuticals [P]NYSE: TEVA |
110.5 (Jul 2015) | 10.69 | 48.3 | 16.2 | 24.4 | 32.7 | 13.2 | 70.5 | 29.3 |
| 33 | Moderna[P] NASDAQ: MRNA |
71.9 (Dec 2020) | 68.5 | 45.0 | - | |||||
| 34 | Ultragenyx[P] NASDAQ: RARE |
11.9 (Dec 2020) | 11.5 | 1.0 | 0.5 | - | ||||
| 35 1 | .svg.png.webp){kind=small} / Bausch Health[P]TSX: BHC |
31.2 (Jul 2015) | 7.20 | 10.6 | 10 | 21 | 4.5 | 8.1 | 9.0 | - |
| 36 1 | Mylan[P] NASDAQ: MYL |
38.8 (Dec 2015) | NA | 10.4 | 14.1 | 27.5 | 30.3 | 38.8 | 33.2 | 35.7 |
Footnotes
- The change is the companies' relative position in this list, compared to their relative position in the prior year; i.e, an increase would be moving closer to rank 1 and vice versa
References
- "Symbol Lookup from Yahoo Finance". finance.yahoo.com. Retrieved 2020-12-23.
- "Healthcare – Google Finance".
- "Healthcare – Google Finance".
- "The World's Biggest Public Companies". Forbes.
- "• Top biotech and pharmaceutical companies market value 2015 - Statistic". Statista.
| History |  | ||||
|---|---|---|---|---|---|
| Branches | |||||
| Biological concepts | |||||
| General concepts |
| ||||
| Basic techniques and tools |
| ||||
| Applications | |||||
| Interdisciplinary fields | |||||
| Lists | |||||
| |||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.